Helping the brain adapt to new technologies for restoring sight
Learning to see again: biological constraints on cortical plasticity and the implications for sight restoration technologies
This project explores how the brain can learn to use new technologies like implants to help people who are blind see again.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11090338 on NIH RePORTER |
What this research studies
New technologies like retinal and cortical implants are making it possible for some people who are blind to regain a form of sight. However, the vision provided by these artificial devices is often quite different from natural sight. This project uses advanced computer models, built from real brain data, to understand how the brain adapts to these new visual signals. We are simulating these unique visual experiences in people with normal vision to learn how the brain can best make sense of artificial input. The ultimate goal is to help patients achieve the best possible vision with these innovative technologies.
Who could benefit from this research
Good fit: This research is relevant for individuals who are blind or have severe vision impairment and may be candidates for future sight restoration technologies.
Not a fit: Patients not seeking or unable to receive sight restoration technologies may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to improved training and device designs, helping blind individuals achieve clearer and more useful vision with sight restoration technologies.
How similar studies have performed: While sight restoration technologies have shown promising progress, this specific approach of understanding cortical plasticity for artificial visual input through modeling and simulation is a novel area of focus.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Fine, Ione — University of Washington
- Study coordinator: Fine, Ione
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.